Multiformat T-Cell-Engaging Bispecific Antibodies Targeting Human Breast Cancers-Reference-Cited by-同舟云学术

Multiformat T-Cell-Engaging Bispecific Antibodies Targeting Human Breast Cancers

Published:2015-04-27 Issue:24 Volume:54 Page:7022-7027
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Cao Yu,Axup Jun Y.,Ma Jennifer S. Y.,Wang Rongsheng E.,Choi Seihyun,Tardif Virginie,Lim Reyna K. V.,Pugh Holly M.,Lawson Brian R.,Welzel Gus,Kazane Stephanie A.,Sun Ying,Tian Feng,Srinagesh Shailaja,Javahishvili Tsotne,Schultz Peter G.,Kim Chan Hyuk

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/anie.201500799/fullpdf

Reference41 articles.

1. Trastuzumab Emtansine: A Novel Antibody–Drug Conjugate for HER2-Positive Breast Cancer

2. Pertuzumab

3. HER2 Amplification Ratios by Fluorescence In Situ Hybridization and Correlation with Immunohistochemistry in a Cohort of 6556 Breast Cancer Tissues

4. Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overview;Frontiers in Immunology;2023-12-04

2. Applications of genetic code expansion technology in eukaryotes;Protein & Cell;2023-10-17

3. Synthesis of Bispecific Antibody Conjugates Using Functionalized Poly-ADP-ribose Polymers;Biochemistry;2023-02-23

4. A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL;Blood;2022-10-20

5. Chemical and Enzymatic Methods for Post-Translational Protein–Protein Conjugation;Journal of the American Chemical Society;2022-08-01